A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

计划入组 316 人 · 首次发布于 2020 年 2 月 5 日

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

计划入组 13 人 · 首次发布于 2023 年 6 月 1 日

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

计划入组 102 人 · 首次发布于 2018 年 8 月 3 日

Azacitidine/Cedazuridine

Cedazuridine(Inqovi 5 Tablet Pack, Inaqovi)

C₉H₁₄F₂N₂O₅

Azacitidine(Onureg, Vidaza, Azacitidine Accord, Azacitidine betapharm, Azacitidine Mylan, Azacitidine Kabi, Azacitidine Celgene)

C₈H₁₂N₄O₅ · Rx

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Sichuan Huiyu Pharmaceutical Co., Ltd.

Five-Day Azacitidine Regimen Shows Superior Survival Outcomes in Lower-Risk MDS Patients

NCCN Announces Projects to Study Oral Decitabine and Cedazuridine

Oral Decitabine and Cedazuridine Included in NIH's MyeloMATCH Precision Medicine Trials